Liposomal irinotecan (Onivyde): Exemplifying the benefits of nanotherapeutic drugs von Milano, Gérard, Innocenti, Federico, Minami, Hironobu

Volltext

Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure von Hughes, Timothy P, Mauro, Michael J, Cortes, Jorge E, Minami, Hironobu, Rea, Delphine, DeAngelo, Daniel J, Breccia, Massimo, Goh, Yeow-Tee, Talpaz, Moshe, Hochhaus, Andreas, le Coutre, Philipp, Ottmann, Oliver, Heinrich, Michael C, Steegmann, Juan L, Deininger, Michael W.N, Janssen, Jeroen J.W.M, Mahon, Francois-Xavier, Minami, Yosuke, Yeung, David, Ross, David M, Tallman, Martin S, Park, Jae H, Druker, Brian J, Hynds, David, Duan, Yuyan, Meille, Christophe, Hourcade-Potelleret, Florence, Vanasse, K. Gary, Lang, Fabian, Kim, Dong-Wook

Volltext

Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer von IMAMURA, YOSHINORI, MUKOHARA, TORU, SHIMONO, YOHEI, FUNAKOSHI, YOHEI, CHAYAHARA, NAOKO, TOYODA, MASANORI, KIYOTA, NAOMI, TAKAO, SHINTARO, KONO, SEISHI, NAKATSURA, TETSUYA, MINAMI, HIRONOBU

Volltext

Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma von Yamazaki, Naoya, Kiyohara, Yoshio, Uhara, Hisashi, Iizuka, Hajime, Uehara, Jiro, Otsuka, Fujio, Fujisawa, Yasuhiro, Takenouchi, Tatsuya, Isei, Taiki, Iwatsuki, Keiji, Uchi, Hiroshi, Ihn, Hironobu, Minami, Hironobu, Tahara, Hideaki

Volltext

Efficacy and safety of nivolumab in Japanese patients with uterine cervical cancer, uterine corpus cancer, or soft tissue sarcoma: Multicenter, open‐label phase 2 trial von Tamura, Kenji, Hasegawa, Kosei, Katsumata, Noriyuki, Matsumoto, Koji, Mukai, Hirofumi, Takahashi, Shunji, Nomura, Hiroyuki, Minami, Hironobu

Volltext

miR-221 Targets QKI to Enhance the Tumorigenic Capacity of Human Colorectal Cancer Stem Cells von Mukohyama, Junko, Isobe, Taichi, Hu, Qingjiang, Hayashi, Takanori, Watanabe, Takashi, Maeda, Masao, Yanagi, Hisano, Qian, Xin, Yamashita, Kimihiro, Minami, Hironobu, Mimori, Koshi, Sahoo, Debashis, Kakeji, Yoshihiro, Suzuki, Akira, Dalerba, Piero, Shimono, Yohei

Volltext

Efficacy and safety of nivolumab in Japanese patients with previously untreated advanced melanoma: A phase II study von Yamazaki, Naoya, Kiyohara, Yoshio, Uhara, Hisashi, Uehara, Jiro, Fujimoto, Manabu, Takenouchi, Tatsuya, Otsuka, Masaki, Uchi, Hiroshi, Ihn, Hironobu, Minami, Hironobu

Volltext

A phase I, dose-escalation study of oral PIM447 in Japanese patients with relapsed and/or refractory multiple myeloma von Iida, Shinsuke, Sunami, Kazutaka, Minami, Hironobu, Hatake, Kiyohiko, Sekiguchi, Risa, Natsume, Kazuto, Ishikawa, Norifumi, Rinne, Mikael, Taniwaki, Masafumi

Volltext

Long‐term follow up of nivolumab in previously untreated Japanese patients with advanced or recurrent malignant melanoma von Yamazaki, Naoya, Kiyohara, Yoshio, Uhara, Hisashi, Uehara, Jiro, Fujisawa, Yasuhiro, Takenouchi, Tatsuya, Otsuka, Masaki, Uchi, Hiroshi, Ihn, Hironobu, Hatsumichi, Masahiro, Minami, Hironobu

Volltext

Safety and efficacy of nivolumab plus bevacizumab, paclitaxel for HER2-negative metastatic breast cancer: Primary results and biomarker data from a phase 2 trial (WJOG9917B) von Ozaki, Yukinori, Tsurutani, Junji, Mukohara, Toru, Iwasa, Tsutomu, Takahashi, Masato, Tanabe, Yuko, Kawabata, Hidetaka, Masuda, Norikazu, Futamura, Manabu, Minami, Hironobu, Matsumoto, Koji, Yoshimura, Kenichi, Kitano, Shigehisa, Takano, Toshimi

Volltext

SY07-1 New guidelines for clinical evaluation of anti-cancer drugs in Japan von Minami, Hironobu

Volltext

PSY3-5 The future of “Onco-OO” von Minami, Hironobu

Volltext

A Pathogenic NRAS c.38G>A (p.G13D) Mutation in RARA Translocation-negative Acute Promyelocytic-like Leukemia with Concomitant Myelodysplastic Syndrome von Goto, Hideaki, Yakushijin, Kimikazu, Adachi, Yoko, Matsumoto, Hisayuki, Yamamoto, Katsuya, Matsumoto, Sakuya, Yamashita, Tomoe, Higashime, Ako, Kawaguchi, Koji, Kurata, Keiji, Matsuoka, Hiroshi, Minami, Hironobu

Volltext

Incidence of venous thromboembolism in patients with solid cancers in Japan: retrospective study of 2735 patients von Nose, Taku, Imamura, Yoshinori, Ohata, Shinya, Kimbara, Shiro, Miyata, Yoshiharu, Hyogo, Yasuko, Fujishima, Yoshimi, Funakoshi, Yohei, Toyoda, Masanori, Kiyota, Naomi, Minami, Hironobu

Volltext

A Novel Serum Metabolomics-Based Diagnostic Approach to Pancreatic Cancer von KOBAYASHI, Takashi, NISHIUMI, Shin, HAYASHI, Nobuhide, KAWANO, Seiji, FUJIWARA, Yutaka, MINAMI, Hironobu, TAKENAWA, Tadaomi, AZUMA, Takeshi, YOSHIDA, Masaru, IKEDA, Atsuki, YOSHIE, Tomoo, SAKAI, Aya, MATSUBARA, Atsuki, IZUMI, Yoshihiro, TSUMURA, Hidetaka, TSUDA, Masahiro, NISHISAKI, Hogara

Volltext

Protocol for a phase II study to evaluate the efficacy and safety of nivolumab as a postoperative adjuvant therapy for patients with esophageal cancer treated with preoperative doc... von Goto, Hironobu, Oshikiri, Taro, Kato, Takashi, Nagatani, Yoshiaki, Funakoshi, Yohei, Koterazawa, Yasufumi, Sawada, Ryuichiro, Harada, Hitoshi, Urakawa, Naoki, Hasegawa, Hiroshi, Kanaji, Shingo, Yamashita, Kimihiro, Matsuda, Takeru, Minami, Hironobu, Kakeji, Yoshihiro

Volltext

Phase I study of glasdegib (PF‐04449913), an oral smoothened inhibitor, in Japanese patients with select hematologic malignancies von Minami, Yosuke, Minami, Hironobu, Miyamoto, Toshihiro, Yoshimoto, Goichi, Kobayashi, Yukio, Munakata, Wataru, Onishi, Yasushi, Kobayashi, Masahiro, Ikuta, Mari, Chan, Geoffrey, Woolfson, Adrian, Ono, Chiho, Shaik, Mohammed Naveed, Fujii, Yosuke, Zheng, Xianxian, Naoe, Tomoki

Volltext

Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results von Rai, Shinya, Kim, Won Seog, Ando, Kiyoshi, Choi, Ilseung, Izutsu, Koji, Tsukamoto, Norifumi, Yokoyama, Masahiro, Tsukasaki, Kunihiro, Kuroda, Junya, Ando, Jun, Hidaka, Michihiro, Koh, Youngil, Shibayama, Hirohiko, Uchida, Toshiki, Yang, Deok Hwan, Ishitsuka, Kenji, Ishizawa, Kenichi, Kim, Jin Seok, Lee, Hong Ghi, Minami, Hironobu, Eom, Hyeon Seok, Kurosawa, Mitsutoshi, Lee, Jae Hoon, Lee, Jong Seok, Lee, Won Sik, Nagai, Hirokazu, Shindo, Takero, Yoon, Dok Hyun, Yoshida, Shinichiro, Gillings, Mireille, Onogi, Hiroshi, Tobinai, Kensei

Volltext

Biclonal Diffuse Large B-cell Lymphoma Commonly Characterized by Partial Trisomy 18q Involving MALT1 and BCL2 von Yamamoto, Katsuya, Kawamoto, Shinichiro, Chijiki, Ruri, Watanabe, Marika, Matsumoto, Sakuya, Kitao, Akihito, Mizutani, Yu, Kajimoto, Kazuyoshi, Hayashi, Yoshitake, Yakushijin, Kimikazu, Minami, Hironobu

Volltext

Effect of axitinib (AG‐013736) on fatigue, thyroid‐stimulating hormone, and biomarkers: A phase I study in Japanese patients von Mukohara, Toru, Nakajima, Hikaru, Mukai, Hirofumi, Nagai, Shunji, Itoh, Kuniaki, Umeyama, Yoshiko, Hashimoto, Junichi, Minami, Hironobu

Volltext